FindTrial
Sign In

Establishment of a risk evaluation system for prediction of aspirin-induced upper gastrointestinal bleeding in elderly users

Establishment of a risk evaluation system for prediction of aspirin-induced upper gastrointestinal bleeding in elderly users

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044424
Enrollment
Unknown
Registered
2021-03-18
Start date
2021-07-01
Completion date
Unknown
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspirin in the elderly causes upper gastrointestinal bleeding

Interventions

Follow-up group taking aspirin:Aspirin Taking

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 60 and < 90 years; 2. Have taken ASA in recent 30 days and at the prescribed dose for more than 7 days consecutively (The patients with UGIB will be included in the case group, and those without UGIB in the telephone follow-up period will be included in the control group); 3. no severe bleeding tendency; 4. negative in fecal occult blood test; 5. can be followed up regularly; 6. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Malignant ulcer bleeding; 2. Suffering from peptic ulcer and gastroesophageal variceal bleeding at the same time; 3. have contradictions of endoscopy.

Design outcomes

Primary

MeasureTime frame
vital signs;blood routine;Stool routine-occult blood test;—

Secondary

MeasureTime frame
height;weight;biochemical parameters;coagulation;C13 breath test;complication;gastroscopy;—

Countries

China

Contacts

Public ContactJianyu Hao

Beijing Chaoyang Hospital, Capital Medical University

haojianyu@ccmu.edu.cn+86 13910230892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026